Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications.
Journal Information
Full Title: Curr Obes Rep
Abbreviation: Curr Obes Rep
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Competing InterestsNo competiting interests to declare. EmploymentNo employment to declare. Financial InterestsNo financial Interests to declare. Non-financial InterestsNo non-financial Interests to declare. Competing Interests No competiting interests to declare."
Funding Disclosure
Evidence found in paper:
"Funding Open access funding provided by Università degli Studi di Napoli Federico II within the CRUI-CARE Agreement. The authors did not receive support from any organization for the submitted work."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025